PTGX Protagonist Therapeutics, Inc. - Common Stock
$151,85
Kurs · Aug 21, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$54–$161
92% of range
Analystenbewertung
BUY
20 analysts
Kursziel
$165
+9% upside
P/E (TTM)
-76.0
ROE
-20.3%
Nettogewinnmarge
-282.8%
PTGX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$151.85
Marktkapitalisierung
$9.75B
P/E (TTM)
-76.0
EPS (TTM)
$-2.05
Umsatz (TTM)
$46M
Dividendenrendite
—
ROE
-20.3%
Verschuldungsgrad
—
52W-Spanne
$55 – $161
PTGX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$46M
2017-12-31
→
2025-12-31
EPS
$-2.05
2020-12-31
→
2025-12-31
Freier Cashflow
$56M
2016-12-31
→
2025-12-31
Margen
-282.8%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
PTGX
Peer-Median
P/E (TTM)
-76.0
115.3
P/S (TTM) (K/V (TTM))
211.9
33.9
P/B (K/B)
15.9
3.9
Price / FCF (Kurs / FCF)
173.9
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
PTGX
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-343.6%
—
Net Profit Margin (Nettogewinnmarge)
-282.8%
-93.3%
ROA
-18.4%
-22.2%
ROE
-20.3%
-37.6%
ROIC
-25.9%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
PTGX
Peer-Median
Current Ratio (Liquiditätsgrad)
12.7
5.7
Quick Ratio
12.5
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
PTGX
Peer-Median
Revenue YoY (Umsatz YoY)
-89.4%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
20.1%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
10.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
PTGX
Peer-Median
PTGX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
20 Analysten
- Starker Kauf 7 35,0%
- Kauf 11 55,0%
- Halten 2 10,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
13 Analysten · 2026-08-16
Median
$167.00
Jetzt
$151.85
Tief
$112.00
Hoch
$225.00
Median-Ziel
$167.00
+10,0%
Mittelwert-Ziel
$165.31
+8,9%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.11%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $2.29 | $2.12 | 0.17% |
| 31. März 2026 | $0.05 | $-0.54 | 0.59% |
| 31. Dezember 2025 | $-0.69 | $-0.50 | -0.19% |
| 30. September 2025 | $-0.62 | $-0.65 | 0.03% |
| 30. Juni 2025 | $-0.55 | $-0.59 | 0.04% |
| 31. März 2025 | $-0.19 | $-0.24 | 0.05% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| PCVX | $6.05B | -8.2 | — | — | -26.6% | — |
| TWST | $1.71B | -21.6 | 20.3% | -20.6% | -17.0% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
| TGTX | $4.63B | 10.8 | 87.3% | 72.6% | 96.7% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $46M | $434M | $60M | $27M | $27M | $29M | $231.0K | $31M | $20M | |
| R&D Expense | $159M | $138M | $120M | $126M | $126M | $75M | $65M | $59M | $46M | |
| SG&A Expense | $45M | $43M | $33M | $32M | $27M | $19M | $16M | $14M | $12M | |
| Operating Expenses | $204M | $182M | $154M | $158M | $153M | $93M | $81M | $73M | $58M | |
| Operating Income | $-158M | $253M | $-94M | $-131M | $-126M | $-65M | $-81M | $-42M | $-38M | |
| Interest Expense | · | · | · | · | · | $598.0K | $169.0K | · | · | |
| Interest Income | $29M | $26M | $15M | $4M | $443.0K | $900.0K | $3M | $3M | $948.0K | |
| Other Non-op | $27.0K | $250.0K | $-201.0K | $-80.0K | $-149.0K | $-46.0K | $-1.0K | $-20.0K | $-8.0K | |
| Pretax Income | $-129M | $279M | $-79M | $-127M | $-126M | $-65M | $-78M | $-40M | $-37M | |
| Income Tax | $838.0K | $4M | $0 | $0 | $0 | $1M | $-691.0K | $-799.0K | $0 | |
| Net Income | $-130M | $275M | $-79M | $-127M | $-126M | $-66M | $-77M | $-39M | $-37M | |
| EPS (Basic) | $-2.05 | $4.47 | $-1.39 | $-2.60 | $-2.71 | $-1.92 | · | · | · | |
| EPS (Diluted) | $-2.05 | $4.23 | $-1.39 | $-2.60 | $-2.71 | $-1.92 | · | · | · | |
| Shares (Basic) | 63,573,048 | 61,566,989 | 56,763,559 | 49,042,232 | 46,322,910 | 34,396,446 | · | · | · | |
| Shares (Diluted) | 63,573,048 | 65,077,722 | 56,763,559 | 49,042,232 | 46,322,910 | 34,396,446 | · | · | · | |
| EBITDA | $-157M | $254M | $-93M | $-130M | $-125M | $-64M | $-80M | $-42M | $-37M |
Bilanz 22
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $128M | $97M | $187M | $126M | $124M | $117M | $33M | $82M | $106M | |
| Short-term Investments | $439M | $322M | $155M | $112M | $203M | $188M | $100M | $47M | $38M | |
| Prepaid Expense | $10M | $8M | $4M | $6M | $9M | $6M | $6M | $3M | $4M | |
| Other Current Assets | $10.0K | $248.0K | $76.0K | $42.0K | · | · | · | · | $1M | |
| Current Assets | $578M | $592M | $356M | $243M | $341M | $316M | $145M | $138M | $151M | |
| PP&E (Net) | $4M | $3M | $1M | $2M | $2M | $1M | $2M | $861.0K | $879.0K | |
| PP&E (Gross) | $12M | $10M | $7M | $7M | $6M | $5M | $4M | $3M | $2M | |
| Accum. Depreciation | $8M | $7M | $6M | $5M | $4M | $3M | $3M | $2M | $2M | |
| Total Assets | $668M | $745M | $358M | $248M | $348M | $324M | $155M | $139M | $164M | |
| Accounts Payable | $5M | $2M | $772.0K | $4M | $2M | $3M | $3M | $6M | $1M | |
| Accrued Liabilities | $28M | $24M | $19M | $25M | $38M | $18M | $12M | $11M | $10M | |
| Current Liabilities | $45M | $47M | $21M | $31M | $44M | $40M | $35M | $26M | $43M | |
| Capital Leases | $8M | $10M | · | $1M | $4M | $4M | $6M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $121.0K | · | · | · | |
| Total Liabilities | $53M | $69M | $21M | $32M | $48M | $45M | $75M | $27M | $43M | |
| Long-term Debt | · | · | · | · | · | · | $10M | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | · | · | · | · | · | $0 | |
| Retained Earnings | $-471M | $-341M | $-616M | $-537M | $-409M | $-284M | $-218M | $-140M | $-102M | |
| AOCI | $641.0K | $-82.0K | $-105.0K | $-359.0K | $-299.0K | $28.0K | $-221.0K | $-233.0K | $-6.0K | |
| Stockholders' Equity | $615M | $675M | $337M | $216M | $300M | $280M | $80M | $113M | $121M | |
| Liabilities + Equity | $668M | $745M | $358M | $248M | $348M | $324M | $155M | $139M | $164M | |
| Shares Outstanding | 62,577,897 | 61,035,139 | 57,708,613 | 49,339,252 | 47,838,330 | 43,745,465 | 27,217,649 | 23,187,219 | 21,088,306 |
Cashflow 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $826.0K | $977.0K | $1M | $813.0K | $948.0K | $732.0K | $527.0K | $406.0K | |
| Stock-based Comp | $46M | $38M | $29M | $24M | $16M | $8M | $8M | $7M | $4M | |
| Deferred Tax | · | · | · | · | · | $1M | $-775.0K | $-799.0K | · | |
| Other Non-cash | $141M | $-129M | $-22M | $-6M | $478.0K | $-16M | $27M | $-18M | $36M | |
| Operating Cash Flow | $58M | $184M | $-70M | $-108M | $-108M | $-72M | $-42M | $-50M | $4M | |
| CapEx | $2M | $1M | $609.0K | $795.0K | $1M | $471.0K | $967.0K | $486.0K | $666.0K | |
| Investing Cash Flow | $-49M | $-299M | $-39M | $91M | $-16M | $-91M | $-54M | $2M | $16M | |
| Debt Issued | · | · | · | · | · | · | $10M | · | · | |
| Net Debt Issued | · | · | · | · | · | $-11M | · | · | · | |
| Stock Issued | · | · | $108M | · | $124M | $213M | $34M | $2M | · | |
| Net Stock Activity | · | · | $108M | · | $124M | $213M | $34M | $2M | · | |
| Financing Cash Flow | $23M | $26M | $170M | $19M | $130M | $248M | $46M | $24M | $66M | |
| Net Change in Cash | $31M | $-89M | $61M | $2M | $6M | $84M | $-49M | $-24M | $85M | |
| Taxes Paid | $4M | $2M | · | · | · | · | · | · | · | |
| Free Cash Flow | $56M | $183M | $-71M | $-109M | $-109M | $-73M | $-42M | $-50M | $3M | |
| Levered FCF | · | · | · | · | · | $-74M | $-43M | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -343.6% | 58.2% | -156.1% | -494.2% | -460.0% | · | · | -136.7% | · | |
| Net Margin | -282.8% | 63.3% | -131.6% | -479.3% | -458.9% | · | · | -125.9% | · | |
| Pretax Margin | -281.0% | 64.3% | -131.6% | -479.3% | -458.9% | · | · | -128.4% | · | |
| EBITDA Margin | -340.9% | 58.4% | -154.5% | -490.4% | -457.0% | · | · | -135.0% | · | |
| ROA | -18.4% | 49.9% | -26.1% | -42.8% | -37.4% | -27.6% | -52.4% | -25.7% | -28.7% | |
| ROE | -20.3% | 45.6% | -24.7% | -55.5% | -39.9% | -29.4% | -88.0% | -32.9% | -35.5% | |
| ROIC | -25.9% | 36.9% | -27.8% | -60.9% | -41.9% | -23.5% | -99.8% | -38.3% | -31.4% |
Liquidität & Solvenz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.7 | 12.5 | 16.7 | 7.8 | 7.7 | 7.8 | 4.1 | 5.3 | 3.5 | |
| Quick Ratio | 12.5 | 8.8 | 16.1 | 7.6 | 7.4 | 7.6 | 3.8 | 4.9 | 3.4 | |
| Interest Coverage | · | · | · | · | · | -107.9 | -476.5 | · | · |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.8 | 0.2 | 0.1 | 0.1 | · | · | 0.2 | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -89.4% | 624.1% | 125.7% | -2.8% | -4.4% | · | · | · | · | |
| Revenue CAGR 3Y | 20.1% | 151.3% | 28.0% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.0% | · | · | · | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $46M | $434M | $60M | $27M | $27M | $29M | $231.0K | $31M | $20M | |
| Net Income TTM | $-130M | $275M | $-79M | $-127M | $-126M | $-66M | $-77M | $-39M | $-37M | |
| Market Cap | $5.47B | $2.36B | $1.32B | $538M | $1.64B | $882M | $192M | $156M | $439M | |
| P/E | -42.6 | 9.1 | -16.5 | -4.2 | -12.6 | -10.5 | · | · | · | |
| P/S | 118.8 | 5.4 | 22.1 | 20.3 | 59.8 | 30.8 | 830.7 | 5.0 | 21.9 | |
| P/B | 8.9 | 3.5 | 3.9 | 2.5 | 5.5 | 3.2 | 2.4 | 1.4 | 3.6 | |
| P / Tangible Book | 8.9 | 3.5 | 3.9 | 2.5 | 5.5 | 3.2 | · | · | · | |
| P / Cash Flow | 94.8 | 12.8 | -18.8 | -5.0 | -15.2 | -12.2 | -4.6 | -3.1 | 113.3 | |
| P / FCF | 97.5 | 12.9 | -18.7 | -4.9 | -15.0 | -12.1 | -4.5 | -3.1 | 136.8 | |
| Earnings Yield | -2.4% | 11.0% | -6.1% | -23.8% | -7.9% | -9.5% | · | · | · |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $213M | $56M | $7M | $5M | $6M | $28M | $171M | $5M | $4M | $255M | $60M | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $42M | $47M | $46M | $40M | $37M | $36M | $35M | $36M | $34M | $34M | $29M | $31M | $33M | $27M | $30M | $25M | |
| SG&A Expense | $13M | $13M | $11M | $11M | $11M | $12M | $9M | $10M | $9M | $15M | $8M | $8M | $9M | $9M | $7M | $7M | |
| Operating Expenses | $55M | $60M | $58M | $51M | $48M | $48M | $44M | $46M | $43M | $49M | $37M | $38M | $42M | $36M | $37M | $32M | |
| Operating Income | $159M | $-4M | $-50M | $-46M | $-42M | $-19M | $127M | $-41M | $-39M | $206M | $23M | $-38M | $-42M | $-36M | $-37M | $-32M | |
| Interest Income | $6M | $6M | $7M | $7M | $7M | $8M | $7M | $8M | $7M | $4M | $4M | $4M | $4M | $2M | $2M | $1M | |
| Other Non-op | $-81.0K | $53.0K | $-124.0K | $33.0K | $36.0K | $82.0K | $31.0K | $141.0K | $97.0K | $-19.0K | $44.0K | $-31.0K | $-19.0K | $-195.0K | $71.0K | $-86.0K | |
| Pretax Income | $165M | $2M | $-44M | $-39M | $-35M | $-12M | $134M | $-34M | $-31M | $211M | $27M | $-34M | $-38M | $-34M | · | · | |
| Income Tax | $2M | $-2M | $666.0K | $0 | $172.0K | $0 | $2M | $-420.0K | $-676.0K | $3M | · | $0 | $0 | $0 | · | · | |
| Net Income | $163M | $4M | $-44M | $-39M | $-35M | $-12M | $132M | $-33M | $-31M | $207M | $27M | $-34M | $-38M | $-34M | $-34M | $-31M | |
| EPS (Basic) | $2.47 | $0.06 | $-0.69 | $-0.62 | $-0.55 | $-0.19 | $2.10 | $-0.54 | $-0.50 | $3.41 | $0.54 | $-0.58 | $-0.68 | $-0.67 | $-0.69 | $-0.64 | |
| EPS (Diluted) | $2.29 | $0.05 | $-0.69 | $-0.62 | $-0.55 | $-0.19 | $2.01 | $-0.54 | $-0.50 | $3.26 | $0.54 | $-0.58 | $-0.68 | $-0.67 | $-0.69 | $-0.64 | |
| Shares (Basic) | 65,935,769 | 65,087,847 | -126,673,627 | 63,772,332 | 63,510,537 | 62,963,806 | -122,361,923 | 61,767,934 | 61,305,289 | 60,855,689 | -109,768,732 | 59,182,899 | 56,775,742 | 50,573,650 | -97,867,857 | 49,107,639 | |
| Shares (Diluted) | 71,007,011 | 70,492,618 | -126,673,627 | 63,772,332 | 63,510,537 | 62,963,806 | -121,590,829 | 61,767,934 | 61,305,289 | 63,595,328 | -109,768,732 | 59,182,899 | 56,775,742 | 50,573,650 | -97,867,857 | 49,107,639 | |
| EBITDA | $159M | $-3M | · | $-46M | $-42M | $-19M | · | $-41M | $-39M | $207M | · | $-38M | $-42M | $-36M | · | $-32M |
Bilanz 21
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $420M | $194M | $128M | $114M | $169M | $140M | $97M | $131M | $356M | $173M | $187M | $231M | $235M | $128M | $126M | $153M | |
| Short-term Investments | $362M | $354M | $439M | $462M | $402M | $435M | $322M | $338M | $208M | $150M | · | $90M | $78M | $103M | · | $115M | |
| Prepaid Expense | $8M | $12M | $10M | $10M | $9M | $9M | $8M | $8M | $7M | $5M | · | $4M | $4M | $5M | · | $9M | |
| Other Current Assets | · | · | $10.0K | $191.0K | $92.0K | · | $248.0K | $3M | $1M | $360.0K | · | $65.0K | · | · | · | · | |
| Current Assets | $807M | $613M | $578M | $586M | $603M | $606M | $592M | $477M | $571M | $628M | · | $325M | $317M | $236M | · | $277M | |
| PP&E (Net) | $3M | $4M | $4M | $4M | $4M | $4M | $3M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $2M | |
| PP&E (Gross) | $13M | $12M | $12M | $12M | $12M | $11M | $10M | $9M | $8M | $8M | · | $7M | $7M | $7M | · | $7M | |
| Accum. Depreciation | $9M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | · | $6M | $6M | $5M | · | $5M | |
| Other Non-current Assets | $832.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $886M | $697M | $668M | $702M | $718M | $742M | $745M | $604M | $615M | $629M | · | $330M | $320M | $240M | · | $282M | |
| Accounts Payable | $3M | $8M | $5M | $6M | $3M | $3M | $2M | $3M | $4M | $4M | · | $1M | $5M | $4M | · | $5M | |
| Accrued Liabilities | $22M | $17M | $28M | $23M | $15M | $12M | $24M | $21M | $15M | $16M | · | $25M | $19M | $17M | · | $30M | |
| Current Liabilities | $37M | $35M | $45M | $45M | $36M | $35M | $47M | $45M | $42M | $40M | · | $28M | $26M | $23M | · | $37M | |
| Capital Leases | $7M | $7M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | · | · | · | · | $462.0K | · | $2M | |
| Total Liabilities | $44M | $42M | $53M | $56M | $50M | $53M | $69M | $72M | $73M | $69M | · | $28M | $26M | $24M | · | $39M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | · | $1.0K | $1.0K | $1.0K | · | · | |
| Retained Earnings | $-304M | $-467M | $-471M | $-426M | $-387M | $-352M | $-341M | $-472M | $-439M | $-408M | · | $-643M | $-609M | $-570M | · | $-503M | |
| AOCI | $-828.0K | $-269.0K | $641.0K | $525.0K | $-15.0K | $85.0K | $-82.0K | $1M | $-249.0K | $-229.0K | · | $-170.0K | $-198.0K | $-122.0K | · | $-480.0K | |
| Stockholders' Equity | $842M | $655M | $615M | $645M | $668M | $689M | $675M | $532M | $541M | $560M | $337M | $302M | $294M | $216M | $216M | $244M | |
| Liabilities + Equity | $886M | $697M | $668M | $702M | $718M | $742M | $745M | $604M | $615M | $629M | · | $330M | $320M | $240M | · | $282M | |
| Shares Outstanding | 64,672,032 | 64,227,057 | 62,577,897 | 62,447,102 | 62,107,572 | 61,928,760 | 61,035,139 | 59,521,903 | 58,762,063 | 58,600,787 | 57,708,613 | 57,647,476 | 57,494,185 | 51,440,503 | 49,339,252 | 49,198,411 |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $397.0K | $407.0K | $376.0K | $361.0K | $304.0K | $239.0K | $118.0K | $231.0K | $241.0K | $236.0K | $248.0K | $244.0K | $237.0K | $248.0K | $256.0K | $270.0K | |
| Stock-based Comp | $14M | $15M | $11M | $11M | $11M | $14M | $9M | $10M | $9M | $9M | $7M | $7M | $8M | $8M | $6M | $6M | |
| Other Non-cash | · | $-68M | · | · | · | $123M | · | · | · | $-244M | · | · | · | $-8M | · | · | |
| Operating Cash Flow | $219M | $-49M | $-37M | $-2M | $-29M | $125M | $-29M | $-28M | $269M | $-27M | $17M | $-27M | $-26M | $-34M | $-32M | $-25M | |
| CapEx | $168.0K | $215.0K | $144.0K | $88.0K | $813.0K | $545.0K | $310.0K | $775.0K | $28.0K | $242.0K | $19.0K | $404.0K | $176.0K | $10.0K | $70.0K | $162.0K | |
| Investing Cash Flow | $-2M | $91M | $49M | $-59M | $55M | $-94M | $-9M | $-209M | $-88M | $6M | $-61M | $-14M | $26M | $10M | $4M | $57M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $8.0K | $-78.0K | · | · | · | · | |
| Financing Cash Flow | $10M | $23M | $3M | $6M | $3M | $11M | $4M | $12M | $3M | $7M | $527.0K | $35M | $108M | $26M | $553.0K | $680.0K | |
| Net Change in Cash | $226M | $65M | $15M | $-55M | $29M | $42M | $-34M | $-225M | $183M | $-14M | $-44M | $-5M | $108M | $2M | $-27M | $33M | |
| Free Cash Flow | · | $-49M | · | · | · | $125M | · | · | · | $-28M | · | · | · | $-34M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 74.4% | -6.5% | · | -985.2% | -758.0% | -68.2% | · | -886.7% | -931.0% | 80.9% | · | · | · | · | · | · | |
| Net Margin | 76.3% | 6.7% | · | -834.9% | -627.0% | -41.1% | · | -710.4% | -734.7% | 81.3% | · | · | · | · | · | · | |
| Pretax Margin | 77.3% | 4.0% | · | -834.9% | -623.9% | -41.1% | · | -719.4% | -751.0% | 82.6% | · | · | · | · | · | · | |
| EBITDA Margin | 74.4% | -5.8% | · | -985.2% | -758.0% | -67.3% | · | -886.7% | -931.0% | 81.0% | · | · | · | · | · | · | |
| ROA | 20.3% | 0.53% | · | -6.0% | -5.2% | -1.7% | · | -7.1% | -6.6% | 47.7% | · | -11.1% | -12.2% | -11.5% | · | -9.5% | |
| ROE | 21.6% | 0.56% | · | -6.7% | -5.8% | -1.9% | · | -8.0% | -7.3% | 53.4% | · | -12.5% | -13.7% | -13.0% | · | -10.9% | |
| ROIC | 18.6% | -0.92% | · | -7.2% | -6.3% | -2.8% | · | -7.7% | -7.0% | 36.2% | · | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.7 | 17.8 | · | 13.0 | 17.0 | 17.3 | · | 10.7 | 13.7 | 15.7 | · | 11.7 | 12.0 | 10.1 | · | 7.5 | |
| Quick Ratio | 21.0 | 15.9 | · | 12.8 | 16.1 | 16.4 | · | 10.5 | 13.6 | 8.1 | · | 11.5 | 11.9 | 9.9 | · | 7.3 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.6 | · | 0.0 | 0.0 | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $280M | $95M | · | $43M | $43M | $292M | · | $264M | $259M | $255M | · | $0 | $859.0K | $27M | · | $37M | |
| Net Income TTM | $93M | $-82M | · | $-119M | $-110M | $132M | · | $109M | $104M | $101M | · | $-138M | $-144M | $-127M | · | $-127M | |
| Market Cap | $7.93B | $6.77B | · | $4.15B | $3.43B | $2.99B | · | $2.68B | $2.04B | $1.70B | · | $962M | $1.59B | $1.18B | · | $415M | |
| P/E | 104.8 | -80.5 | · | -35.0 | -31.1 | 23.8 | · | 27.4 | 23.1 | 21.8 | · | -6.5 | -9.8 | -8.9 | · | -3.2 | |
| P/S | 28.3 | 71.3 | · | 95.9 | 80.4 | 10.3 | · | 10.2 | 7.9 | 6.6 | · | · | 1848.6 | 44.5 | · | 11.2 | |
| P/B | 9.4 | 10.3 | · | 6.4 | 5.1 | 4.3 | · | 5.0 | 3.8 | 3.0 | · | 3.2 | 5.4 | 5.5 | · | 1.7 | |
| P / Tangible Book | 9.4 | 10.3 | · | 6.4 | 5.1 | 4.3 | · | 5.0 | 3.8 | 3.0 | · | 3.2 | 5.4 | 5.5 | · | 1.7 | |
| P / Cash Flow | · | -138.3 | · | · | · | 23.9 | · | · | · | -61.8 | · | · | · | -34.4 | · | · | |
| P / FCF | · | -137.7 | · | · | · | 24.0 | · | · | · | -61.3 | · | · | · | -34.4 | · | · | |
| Earnings Yield | 0.95% | -1.2% | · | -2.9% | -3.2% | 4.2% | · | 3.6% | 4.3% | 4.6% | · | -15.4% | -10.2% | -11.2% | · | -31.0% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $46M | $434M | $60M | $27M | $27M |
| Betriebsgewinnmarge % | -343.6% | 58.2% | -156.1% | -494.2% | -460.0% |
| Nettoergebnis | $-130M | $275M | $-79M | $-127M | $-126M |
| Verwässerte EPS | $-2.05 | $4.23 | $-1.39 | $-2.60 | $-2.71 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 12.7 | 12.5 | 16.7 | 7.8 | 7.7 |
| Quick Ratio | 12.5 | 8.8 | 16.1 | 7.6 | 7.4 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $56M | $183M | $-71M | $-109M | $-109M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 369 Einreicher · $6.0B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 65 (+5 vs. Vorquartal) | 34 (-14 vs. Vorquartal) | 143 (+36 vs. Vorquartal) | 84 (-28 vs. Vorquartal) | +6.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $778.248.897 | 6.348.906 | 12,91% | Aktien |
| RTW INVESTMENTS, LP | $620.398.832 | 5.061.175 | 10,29% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $444.879.349 | 3.629.298 | 7,38% | Aktien |
| STATE STREET CORP | $407.156.089 | 3.321.554 | 6,75% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $349.769.037 | 2.853.394 | 5,80% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $349.287.787 | 2.849.468 | 5,79% | Aktien |
| JOHNSON & JOHNSON | $300.220.852 | 2.449.183 | 4,98% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $185.989.291 | 1.516.976 | 3,08% | Aktien |
| Woodline Partners LP | $173.349.326 | 1.414.173 | 2,87% | Aktien |
| BANK OF AMERICA CORP /DE/ | $140.547.654 | 1.146.579 | 2,33% | Aktien |
| PERCEPTIVE ADVISORS LLC | $120.358.728 | 981.879 | 2,00% | Aktien |
| ADAR1 Capital Management, LLC | $117.782.587 | 960.863 | 1,95% | Aktien |
| JENNISON ASSOCIATES LLC | $112.878.407 | 920.855 | 1,87% | Aktien |
| Alyeska Investment Group, L.P. | $109.010.149 | 889.298 | 1,81% | Aktien |
| Hood River Capital Management LLC | $108.206.024 | 882.738 | 1,79% | Aktien |
| Driehaus Capital Management LLC | $89.612.477 | 731.053 | 1,49% | Aktien |
| Clearbridge Investments, LLC | $88.911.554 | 725.335 | 1,47% | Aktien |
| FMR LLC | $82.247.135 | 670.967 | 1,36% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $73.376.587 | 598.600 | 1,22% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $71.559.017 | 583.774 | 1,19% | Aktien |
| Pictet Asset Management Holding SA | $69.624.214 | 567.990 | 1,15% | Aktien |
| GOLDMAN SACHS GROUP INC | $69.261.132 | 565.028 | 1,15% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $53.659.027 | 437.747 | 0,89% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $46.648.554 | 380.556 | 0,77% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $36.954.438 | 301.472 | 0,61% | Aktien |
| 683 Capital Management, LLC | $35.548.200 | 290.000 | 0,59% | Aktien |
| Stephens Investment Management Group LLC | $34.546.967 | 281.832 | 0,57% | Aktien |
| Eagle Health Investments LP | $30.439.311 | 248.322 | 0,50% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $30.311.828 | 247.282 | 0,50% | Aktien |
| NEXTBio Capital Management LP | $26.885.839 | 219.333 | 0,45% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $26.320.868 | 214.724 | 0,44% | Aktien |
| SEB Asset Management AB | $25.737.215 | 209.963 | 0,43% | Aktien |
| Public Sector Pension Investment Board | $25.458.395 | 207.688 | 0,42% | Aktien |
| Bank of New York Mellon Corp | $22.273.031 | 181.702 | 0,37% | Aktien |
| Affinity Asset Advisors, LLC | $21.099.083 | 172.125 | 0,35% | Aktien |
| Fisher Asset Management, LLC | $20.902.831 | 170.524 | 0,35% | Aktien |
| Boxer Capital Management, LLC | $20.838.600 | 170.000 | 0,35% | Aktien |
| Caption Management, LLC | $19.833.444 | 161.800 | 0,33% | Verkaufsoption |
| NAN FUNG TRINITY (HK) LTD | $19.694.929 | 160.670 | 0,33% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $18.592.199 | 151.674 | 0,31% | Aktien |
| Caption Management, LLC | $18.387.000 | 150.000 | 0,30% | Kaufoption |
| ORBIMED ADVISORS LLC | $18.387.000 | 150.000 | 0,30% | Kaufoption |
| AMERIPRISE FINANCIAL INC | $17.395.696 | 141.913 | 0,29% | Aktien |
| RHUMBLINE ADVISERS | $17.317.951 | 141.279 | 0,29% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $17.294.000 | 141.081 | 0,29% | Aktien |
| TD Asset Management Inc | $16.542.171 | 134.950 | 0,27% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $16.428.049 | 134.019 | 0,27% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $13.306.672 | 108.555 | 0,22% | Aktien |
| Catalio Capital Management, LP | $13.091.421 | 106.799 | 0,22% | Aktien |
| Swiss National Bank | $12.552.192 | 102.400 | 0,21% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $12.503.406 | 102.002 | 0,21% | Aktien |
| Opaleye Management Inc. | $12.258.000 | 100.000 | 0,20% | Aktien |
| ASSETMARK, INC | $12.097.052 | 98.687 | 0,20% | Aktien |
| JANUS HENDERSON GROUP PLC | $12.077.934 | 114.575 | 0,20% | Aktien |
| Legal & General Group Plc | $11.363.044 | 92.699 | 0,19% | Aktien |
| ALGERT GLOBAL LLC | $10.750.021 | 87.698 | 0,18% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $10.282.379 | 83.883 | 0,17% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $10.246.953 | 83.594 | 0,17% | Aktien |
| AXIOM INVESTORS LLC /DE | $10.012.702 | 81.683 | 0,17% | Aktien |
| PRUDENTIAL FINANCIAL INC | $9.693.626 | 79.080 | 0,16% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $8.385.940 | 79.563 | 0,14% | Aktien |
| Nuveen, LLC | $8.236.886 | 67.196 | 0,14% | Aktien |
| BlackRock, Inc. | $8.091.628 | 66.011 | 0,13% | Aktien |
| Knott David M Jr | $7.722.540 | 63.000 | 0,13% | Aktien |
| Moody Aldrich Partners LLC | $7.305.891 | 59.601 | 0,12% | Aktien |
| Eversept Partners, LP | $7.171.420 | 58.504 | 0,12% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.994.660 | 57.062 | 0,12% | Aktien |
| Bellevue Group AG | $6.825.500 | 55.682 | 0,11% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.790.932 | 55.400 | 0,11% | Verkaufsoption |
| FIRST TRUST ADVISORS LP | $6.725.351 | 54.865 | 0,11% | Aktien |
| KVP Capital Advisors, LP | $6.496.740 | 53.000 | 0,11% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $6.329.909 | 51.639 | 0,10% | Aktien |
| CASTLEARK MANAGEMENT LLC | $6.198.871 | 50.570 | 0,10% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $6.184.556 | 58.677 | 0,10% | Aktien |
| Granahan Investment Management, LLC | $6.105.587 | 49.809 | 0,10% | Aktien |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $5.993.427 | 48.894 | 0,10% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $5.597.983 | 45.668 | 0,09% | Aktien |
| Seven Fleet Capital Management LP | $5.565.132 | 45.400 | 0,09% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.565.132 | 45.400 | 0,09% | Kaufoption |
| Caption Management, LLC | $5.516.100 | 45.000 | 0,09% | Aktien |
| EFG Asset Management (North America) Corp. | $5.492.601 | 82.639 | 0,09% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $5.458.365 | 44.529 | 0,09% | Aktien |
| GREAT LAKES ADVISORS, LLC | $5.369.004 | 43.800 | 0,09% | Aktien |
| ORBIMED ADVISORS LLC | $5.160.618 | 42.100 | 0,09% | Aktien |
| Elmind Capital, LP | $4.658.040 | 38.000 | 0,08% | Aktien |
| LMR Partners LLP | $4.658.040 | 38.000 | 0,08% | Aktien |
| Atika Capital Management LLC | $4.444.260 | 36.256 | 0,07% | Aktien |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $4.443.770 | 36.252 | 0,07% | Aktien |
| MetLife Investment Management, LLC | $4.387.383 | 35.792 | 0,07% | Aktien |
| Birchview Capital, LP | $4.292.506 | 35.018 | 0,07% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $4.063.772 | 33.152 | 0,07% | Aktien |
| CITADEL ADVISORS LLC | $3.971.592 | 32.400 | 0,07% | Kaufoption |
| Aquilo Capital Management, LLC | $3.950.625 | 81.692 | 0,07% | Aktien |
| MORGAN STANLEY | $3.857.347 | 31.468 | 0,06% | Aktien |
| Illinois Municipal Retirement Fund | $3.580.684 | 29.211 | 0,06% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $3.574.555 | 29.161 | 0,06% | Aktien |
| Vanguard Global Advisers, LLC | $3.488.995 | 28.463 | 0,06% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $3.474.530 | 28.345 | 0,06% | Aktien |
| DEUTSCHE BANK AG\ | $3.463.620 | 28.256 | 0,06% | Aktien |
| Schonfeld Strategic Advisors LLC | $3.441.064 | 28.072 | 0,06% | Aktien |
Unternehmensinsider 20 Insider · 9 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Asif Ali | Chief Financial Officer | 20. April 2026 S | 59.003 | 0 | 5 | $-7.315.451 |
| Donald A. Kalkofen | Chief Financial Officer | 15. Februar 2022 A | 18.521 | 0 | 0 | $0 |
| Thomas P. O'Neil | Chief Financial Officer | 15. August 2018 A | 30.560 | 0 | 0 | $0 |
| Arturo Molina MD | Chief Medical Officer | 26. März 2026 M | 84.115 | 0 | 6 | $-4.491.766 |
| Suneel Gupta | Chief Development Officer | 26. November 2024 M | 267.433 | 0 | 0 | $0 |
| David Y Liu | Chief R&D Strategy Officer | 16. November 2022 M | 167.590 | 0 | 0 | $0 |
| Samuel R Saks | Chief Medical Officer | 26. Februar 2021 A | 14.000 | 0 | 0 | $0 |
| Richard S Shame | Chief Medical Officer | 28. Februar 2019 A | 32.021 | 0 | 0 | $0 |
| William A Hodder | Sr. VP - Corporate Development | 11. Oktober 2016 A | — | 0 | 0 | $0 |
| William D. Waddill | Direktor | 23. Juni 2026 M | 7.825 | 0 | 8 | $-6.074.420 |
| Bryan Giraudo | Direktor | 7. Mai 2026 M | 12.695 | 0 | 4 | $-5.918.880 |
| Harold E Selick | Direktor | 26. März 2026 M | 60.845 | 0 | 1 | $-2.520.000 |
| Lewis T Williams | Direktor | 17. Februar 2026 M | 7.825 | 0 | 1 | $-1.483.560 |
| Sarah A O'Dowd | Direktor | 2. Januar 2026 A | 7.825 | 0 | 0 | $0 |
| Daniel N Swisher JR | Direktor | 26. Oktober 2023 A | — | 0 | 0 | $0 |
| Sarah B. Noonberg | Direktor | 16. Januar 2023 A | 0 | 0 | 0 | $0 |
| Chaitan Khosla PHD | Direktor | 11. August 2020 M | 0 | 0 | 0 | $0 |
| Armen Shanafelt | Direktor | 29. Mai 2018 A | 2.099.482 | 0 | 0 | $0 |
| Julie Papanek | Direktor | 25. Mai 2017 A | 2.453.255 | 0 | 0 | $0 |
| PATEL DINESH V PH D | — | 11. August 2026 M | 523.478 | 0 | 11 | $-42.337.688 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Lilly Ventures Fund I, LLC, LV Management Group, LLC, S. Edward Torres, Steven E. Hall, Ph.D., Armen B. Shanafelt, Ph.D. ×2 Einreichungen | 8. Juni 2020 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 77 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PSCH · Invesco Exchange-Traded Fund Trust … | 4,64% | 56.832 SH | 20. August 2026 | Täglich |
| PBE · Invesco Exchange-Traded Fund Trust | 3,50% | 91.589 SH | 20. August 2026 | Täglich |
| NBDS · Neuberger Berman ETF Trust | 2,97% | 10.761 NS | 31. Mai 2026 | N-PORT |
| XSMO · Invesco Exchange-Traded Fund Trust | 2,90% | 575.681 SH | 20. August 2026 | Täglich |
| CAFG · Pacer Funds Trust | 2,15% | 4.916 NS | 30. April 2026 | N-PORT |
| RZG · Invesco Exchange-Traded Fund Trust | 2,00% | 17.525 SH | 20. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,96% | 50.321 NS | 30. April 2026 | N-PORT |
| VAMO · Cambria ETF Trust | 0,82% | 6.865 NS | 30. April 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,81% | 71.955 SH | 19. August 2026 | Täglich |
| BBC · ETFis Series Trust I | 0,77% | 2.894 NS | 30. April 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,72% | 61.466 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 0,65% | 456.115 SH | 20. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,62% | 3.561 SH | 20. August 2026 | Täglich |
| IWO · iShares Trust | 0,58% | 570.092 SH | 20. August 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,54% | 8.846 SH | 20. August 2026 | Täglich |
| PSC · Principal Exchange-Traded Funds | 0,47% | 88.659 NS | 30. Juni 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,44% | 65.879 SH | 19. August 2026 | Täglich |
| ESSC · Strategy Shares | 0,41% | 1.068 NS | 30. April 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,41% | 2.139 NS | 31. Mai 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,40% | 211.363 SH | 19. August 2026 | Täglich |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,37% | 19.517 NS | 30. April 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,33% | 3.261 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,32% | 2.361 NS | 31. Mai 2026 | N-PORT |
| IWM · iShares Trust | 0,30% | 1.574.381 SH | 20. August 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,29% | 17.406 NS | 30. April 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,27% | 20.237 NS | 30. April 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,26% | 2.151 NS | 30. April 2026 | N-PORT |
| SAA · ProShares Trust | 0,26% | 705 NS | 31. Mai 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,23% | 354.172 SH | 19. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,22% | 851.812 SH | 19. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,17% | 27.056 SH | 19. August 2026 | Täglich |
| ROSC · Lattice Strategies Trust | 0,17% | 917 NS | 30. April 2026 | N-PORT |
| ISCV · iShares Trust | 0,15% | 6.767 SH | 20. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,15% | 2.739 NS | 31. Mai 2026 | N-PORT |
| ESML · iShares Trust | 0,13% | 24.736 SH | 20. August 2026 | Täglich |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,13% | 17.224 NS | 30. April 2026 | N-PORT |
| ISCB · iShares Trust | 0,13% | 2.384 SH | 20. August 2026 | Täglich |
| ESUM · Strategy Shares | 0,13% | 1.964 NS | 30. April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,12% | 282.329 NS | 31. Mai 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 5.370 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,11% | 20.475 SH | 20. August 2026 | Täglich |
| ISCG · iShares Trust | 0,11% | 7.026 SH | 20. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1.475.028 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,09% | 153.362 SH | 19. August 2026 | Täglich |
| UWM · ProShares Trust | 0,09% | 2.143 NS | 31. Mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,08% | 8.339 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,08% | 23.132 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 693.286 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,07% | 3.168 SH | 20. August 2026 | Täglich |
| URTY · ProShares Trust | 0,06% | 2.169 NS | 31. Mai 2026 | N-PORT |